Fox Chase Cancer Center shared a post on LinkedIn:
“Congratulations to Parth Desai, on receiving the American Society of Clinical Oncology (ASCO) Conquer Cancer Career Development Award.
The prestigious national award will support Dr. Desai’s research into a novel immunotherapy strategy designed to help “immune-cold” tumors respond to treatment.
Building on groundbreaking research at Fox Chase Cancer Center, the project aims to advance promising laboratory discoveries toward an early-phase clinical trial and, ultimately, new treatment options for patients whose cancers do not respond to today’s immunotherapies.”
Other articles from Fox Chase Cancer Center on OncoDaily.